<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02413437</url>
  </required_header>
  <id_info>
    <org_study_id>2014YJZ31</org_study_id>
    <nct_id>NCT02413437</nct_id>
  </id_info>
  <brief_title>A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver Neoplasms</brief_title>
  <official_title>The Multi-center Study of Percutaneous Focal Liver Lesions Biopsy Guided by Contrast-Enhanced Ultrasound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Cancer Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to estimate the clinical value of contrast-enhanced ultrasound
      in percutaneous biopsy for liver occupied lesion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patients with liver neoplasms who need receive percutaneous biopsy were randomized into
      contrast-enhanced ultrasound(CEUS) group and conventional ultrasound(US) group.The aims
      include:

        1. Comparison the diagnostic accuracy rate, specificity and sensitivity between CEUS and US
           group.

        2. Comparison the diagnostic accuracy rate specificity and sensitivity between
           smaller(＜3cm) and larger(≥3cm) nodule group.

        3. To explore operating strategy of contrast-enhanced ultrasound guided biopsy.

        4. To evaluate economic efficiency of contrast-enhanced ultrasound guided biopsy compared
           with conventional ultrasound guided biopsy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>diagnostic accuracy</measure>
    <time_frame>12 months</time_frame>
    <description>diagnostic accuracy=（true positive+ ture negative)/number of parcitipants</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2088</enrollment>
  <condition>Liver Neoplasms</condition>
  <arm_group>
    <arm_group_label>CEUS guided biopsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Biopsy was operated under contrast-enhanced ultrasound-guided</description>
  </arm_group>
  <arm_group>
    <arm_group_label>US guided biopsy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Biopsy was operated under conventional ultrasound-guided</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CEUS guided biopsy</intervention_name>
    <description>Biopsy was operated under contrast-enhanced ultrasound-guided.</description>
    <arm_group_label>CEUS guided biopsy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>US guided biopsy</intervention_name>
    <description>Biopsy was operated under conventional ultrasound-guided.</description>
    <arm_group_label>US guided biopsy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <arm_group_label>CEUS guided biopsy</arm_group_label>
    <arm_group_label>US guided biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with liver occupied lesion who cannot be diagnosed by imaging examination or
             need pathological results

        Exclusion Criteria:

          -  severe anemia

          -  PLT＜60000/mm3,prothrombin activityprothrombin time activity＜70%

          -  women during menstruation, pregnancy, child birth and baby nursing period

          -  patients with severe mental disorder

          -  cardiopulmonary failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kun Yan, master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Cancer Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kun Yan, master</last_name>
    <phone>0086-10-88196910</phone>
    <email>ydbz@vip.sina.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wei Wu, doctor</last_name>
    <phone>0086-10-88196140</phone>
    <email>wuvei@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Cancer Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100142</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kun Yan, Master</last_name>
      <phone>8601088196910</phone>
      <email>ydbz@vip.sina.com</email>
    </contact>
    <contact_backup>
      <last_name>Wei Wu, Doctor</last_name>
      <phone>8601088196140</phone>
      <email>wuvei@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Rossi P, Sileri P, Gentileschi P, Sica GS, Forlini A, Stolfi VM, De Majo A, Coscarella G, Canale S, Gaspari AL. Percutaneous liver biopsy using an ultrasound-guided subcostal route. Dig Dis Sci. 2001 Jan;46(1):128-32.</citation>
    <PMID>11270776</PMID>
  </results_reference>
  <results_reference>
    <citation>Schlottmann K, Klebl F, Zorger N, Feuerbach S, Schölmerich J. Contrast-enhanced ultrasound allows for interventions of hepatic lesions which are invisible on convential B-mode. Z Gastroenterol. 2004 Apr;42(4):303-10.</citation>
    <PMID>15095120</PMID>
  </results_reference>
  <results_reference>
    <citation>Wu W, Chen MH, Yin SS, Yan K, Fan ZH, Yang W, Dai Y, Huo L, Li JY. The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy. AJR Am J Roentgenol. 2006 Sep;187(3):752-61.</citation>
    <PMID>16928941</PMID>
  </results_reference>
  <results_reference>
    <citation>Bang N, Bachmann Nielsen M, Vejborg I, Mellon Mogensen A. Clinical report: contrast enhancement of tumor perfusion as a guidance for biopsy. Eur J Ultrasound. 2000 Dec;12(2):159-61.</citation>
    <PMID>11118924</PMID>
  </results_reference>
  <results_reference>
    <citation>Caturelli E, Biasini E, Bartolucci F, Facciorusso D, Decembrino F, Attino V, Bisceglia M. Diagnosis of hepatocellular carcinoma complicating liver cirrhosis: utility of repeat ultrasound-guided biopsy after unsuccessful first sampling. Cardiovasc Intervent Radiol. 2002 Jul-Aug;25(4):295-9. Epub 2002 Mar 27.</citation>
    <PMID>12324817</PMID>
  </results_reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2015</study_first_submitted>
  <study_first_submitted_qc>April 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2015</study_first_posted>
  <last_update_submitted>May 4, 2017</last_update_submitted>
  <last_update_submitted_qc>May 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Cancer Hospital</investigator_affiliation>
    <investigator_full_name>Kun Yan</investigator_full_name>
    <investigator_title>Beijing Cancer Hospital</investigator_title>
  </responsible_party>
  <keyword>contrast-enhanced ultrasound</keyword>
  <keyword>biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

